Non-immunogenic cancers have best outcomes—according to findings at the Anesthesiology 2021 annual meeting of a large retrospective study comparing 90-day survival.
An app developed by Canadians, and highlighted by a study published by JAMA Oncology, helps identify patients who may have cancer predisposition syndrome.
While initial studies suggest dogs could be helpful in the detection of certain diseases, University of Montreal and Institut Curie researchers are looking to improve upon those initial experiments.
Patients with advanced esophageal squamous cell carcinoma (ESCC) who receive either one or two checkpoint inhibitors along with chemotherapy have significantly improved overall survival than from chemotherapy alone.
